<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Fungal infections are presently considered as an important health problem around the world, and have increased intensely during the last years, due to the immunocompromised patient number. Moreover, the epidemiology has been changed with new fungal agents described as involved in systemic fungal infections [
 <xref rid="B4-molecules-22-01595" ref-type="bibr" class="xref">4</xref>]. Regardless, yeasts as 
 <italic class="italic">Cryptococcus neoformans</italic> and 
 <italic class="italic">Candida</italic> species, and filamentous fungi as 
 <italic class="italic">Aspergillus</italic> species continue to be the most prevalent fungi in systemic mycosis, showing high levels of morbidity and mortality mainly in patients with compromised immunity. On the other hand, superficial cutaneous mycoses, such as mucocutaneous candidiasis, dermatophytosis, and pityriasis versicolor, remain a problem worldwide in healthy and immunocompromised patients [
 <xref rid="B5-molecules-22-01595" ref-type="bibr" class="xref">5</xref>].
</p>
